{"id":"NCT02837952","sponsor":"Pfizer","briefTitle":"A Study of Ibuprofen (IBU) 250mg/APAP 500mg In The Treatment Of Post-Surgical Dental Pain","officialTitle":"A Phase 3, Double-blind, Randomized Safety And Efficacy Study Comparing Multiple Administrations Of Ibu 250 Mg/Apap 500 Mg (Administered As Two Tablets Of Ibu/Apap 125 Mg/250 Mg) To Placebo In The Treatment Of Post Surgical Dental Pain In Adult Subjects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-08-31","primaryCompletion":"2017-02-01","completion":"2017-02-01","firstPosted":"2016-07-20","resultsPosted":"2018-03-05","lastUpdate":"2018-03-05"},"enrollment":123,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pain"],"interventions":[{"type":"DRUG","name":"FDC IBU/APAP 250 mg/500 mg","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Fixed Dose Combination(FDC) IBU/APAP 250 mg/500 mg","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study is being conducted to determine the overall analgesic efficacy and safety of a fixed-dose ibuprofen 250 mg / acetaminophen 500 mg formulation compared to placebo in subjects who are experiencing post operative pain following surgical extraction of 3 or more third molar teeth. A review of any reported adverse events will also be completed.","primaryOutcome":{"measure":"Time-weighted Sum of Pain Intensity Difference Scores on 11-Point Numerical Scale From 0 to 24 Hours Post-dose (SPID11 [0-24])","timeFrame":"0 to 24 hours post dose","effectByArm":[{"arm":"Placebo","deltaMin":-8.13,"sd":9.426},{"arm":"Ibuprofen 250 mg / Acetaminophen 500","deltaMin":64.76,"sd":6.676}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B5061004&StudyName=A+Phase+3%2C+Double-blind%2C+Randomized+Safety+And+Efficacy+Study+Comparing+Multiple+Administrations+Of+Ibu+250+Mg%2Fapap+500+Mg+%28administered+As+Two+Tablets+Of+Ibu%2Fapap+125+Mg%2F250+Mg%29+To+Placebo+In+The+Treatment+Of+Post+Surgical+Dental+Pain+In+Adult+Subjects"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":41},"commonTop":["Nausea","Vomiting","Dizziness","Headache","Vision blurred"]}}